Cell Signaling Technology

Rad54 (D4W3Z) Rabbit Monoclonal Antibody

#15016 · $161

100
Citing papers
9.3k
Combined citations
Supplier page Find this product

Research areas

Extracellular vesicles in disease23MicroRNA in disease regulation13Cancer Immunotherapy and Biomarkers8Cancer, Hypoxia, and Metabolism7Cell death mechanisms and regulation7Circular RNAs in diseases6CAR-T cell therapy research6Cancer-related molecular mechanisms research6

Papers citing this product

1
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
New England Journal of Medicine·2014·3.5k cit.·DOI
2
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nature Communications·2015·1.1k cit.·DOI
3
Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells
The Journal of Experimental Medicine·2015·452 cit.·DOI
4
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Experimental & Molecular Medicine·2019·382 cit.·DOI
5
Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
Genes & Development·2016·317 cit.·DOI
6
Tumour extracellular vesicles and particles induce liver metabolic dysfunction
Nature·2023·255 cit.·DOI
7
CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p
Molecular Cancer·2019·242 cit.·DOI
8
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
Cell·2024·223 cit.·DOI
9
Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
Nature Communications·2012·174 cit.·DOI
10
Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer
Molecular Cancer·2021·140 cit.·DOI